BIS

ProShares UltraShort NASDAQ Biotechnology
*Unless otherwise stated, data provided by FactSet.

BIS Fund Description

BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

BIS Factset Analytics Insight

BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

PERFORMANCE [as of 05/07/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BIS 2.83% 22.50% -3.02% -40.98% -36.32% -33.26% -38.60%
BIS (NAV) -2.31% 20.57% -4.76% -41.71% -36.41% -33.43% -38.69%
NASDAQ Biotechnology Index 0.63% -11.35% -0.99% 18.26% 13.88% 12.55% 16.04%
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BIS Summary Data

ProShares
04/07/10
Open-Ended Fund
0.95%
$10.20M
0.13%

BIS Portfolio Data

0.47%
N/A

BIS Index Data

Market Cap
NASDAQ - Listed
N/A

BIS Fund Structure

Yes
No
No Policy
N/A
N/A
High
-2
Daily

BIS Tax Exposures

20.00% / 39.60%
--
No
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

BIS Factset Analytics Block Liquidity

As of 05/10/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a N/A out of 5.

BIS Tradability

58,451
$1.32M
43,391
$950.21K
0.13%
$0.03
0.00%
300.44% / -74.97%
None
97.00%
50,000
0.87
0.02%
--
414
$22.45
N/A